Characteristics & Business Summary
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It develops MN-166 (ibudilast), an oral anti-inflammatory and...
Income Statement Highlights
(Β₯ Million, except EPS/DPS in Β₯)
| Fiscal Period | FY 2021 | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|---|
| Net Sales | β | β | β | β |
| Operating Profit | β | β | β | β |
| Ordinary Profit | β | β | β | β |
| Net Profit | β | β | β | β |
| EPS | β | β | β | β |
| DPS | β | β | β | β |
Balance Sheet & Valuation Highlights
Total Assets
β
Net Assets (Equity)
β
Equity Ratio
β
ROE (Return on Equity)
β
Cash & Equivalents
β
Interest-Bearing Debt
β
Capital Expenditure (CapEx)
β
Depreciation & Amort.
β